⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

Official Title: Patients' Preferences in the Treatment of Hormone-sensitive Metastatic Prostate Cancer: a Discrete Choice Experiment

Study ID: NCT04590976

Study Description

Brief Summary: Systemic therapy (i.e Androgen Deprivation Therapy with Docetaxel, Enzalutamide, Apalutamide or Abiraterone Acetate) has increased overall survival in men with hormone-sensitive metastatic prostate cancer. Novel local cytoreductive treatments and metastasis directed therapy are being evaluated, these can confer additional harm, but might improve survival. We aim to elicit men's preferences for and willingness to accept trade-offs between potential improved survival and cytoreductive treatment risks using a 'discrete choice experiment'.

Detailed Description: OBJECTIVES: To determine the attributes associated with treatment that are most important to men with hormone-sensitive metastatic prostate cancer (mPCa). To determine men's preferences for, and trade-offs between, the attributes (survival and side-effects) of different treatment options in metastatic prostate cancer including systemic therapy, local and metastases-directed physical therapies. PHASE: Prospective multi-centre observational cohort DESIGN: Discrete choice experiment, single-visit, electronic questionnaire design SAMPLE SIZE: Multi-centre Stage (Stage 3) n = 300 patients POPULATION: Men with newly-diagnosed metastatic prostate cancer who have not consented to a form of local cytoreductive or metastasis directed therapy.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

NHS Grampion, Aberdeen, , United Kingdom

Besti Cadwaladr University, Bangor, , United Kingdom

Ysbyty Gwynedd Hospital, Bangor, , United Kingdom

Hamphire Hospitals NHS Foundation Trust, Basingstoke, , United Kingdom

Royal Bath United Hospital, Bath, , United Kingdom

Bedford Hospital, Bedford, , United Kingdom

Royal Bolton Hospital, Bolton, , United Kingdom

Brighton and Sussex hospital, Brighton, , United Kingdom

East Suffolk and North Essex NHS Foundation Trust, Colchester, , United Kingdom

Dartford and Gravsham NHS Trust, Dartford, , United Kingdom

Royal Devon and Exeter Hospital, Exeter, , United Kingdom

Medway NHS Foundation Trust, Gillingham, , United Kingdom

Northern Lincolnshire and Goole NHS Foundation Trust, Grimsby, , United Kingdom

Royal Surrey County Hospital NHS Foundation Trust, Guildford, , United Kingdom

Imperial College London, Hammersmith, , United Kingdom

North Tees and Hartlepool NHS Foundation Trust, Hartlepool, , United Kingdom

West Middlesex University Hospital, Isleworth, , United Kingdom

Queen Elizabeth Hospital, King's Lynn, , United Kingdom

Kingston Hospital NHS Foundation Trust, Kingston, , United Kingdom

Chelsea and Westminster Hospital, London, , United Kingdom

Imperial College Healthcare NHS Trust, London, , United Kingdom

The Royal Marsden NHS Foundation Trust, Chelsea Research Centre, London, , United Kingdom

Luton and Dunstable University Hospital, Luton, , United Kingdom

Freeman Hospital, Newcastle, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, , United Kingdom

Nottingham University Hospital, Nottingham, , United Kingdom

University Hospitals Dorset NHS Foundation Trust, Poole, , United Kingdom

East Surrey Hospital, Redhill, , United Kingdom

Royal Shrewsbury Hospital, Shrewsbury, , United Kingdom

Southampton General Hospital, University Hospital Southampton NHS Foundation Trust (UHS), Southampton, , United Kingdom

East and North Hertfordshire Nhs Trust, Stevenage, , United Kingdom

Sunderland Royal Hospital, City Hospitals Sunderland NHS Foundation Trust, Sunderland, , United Kingdom

Musgrove Park Hospital - Somerset NHS Foundation Trust, Taunton, , United Kingdom

The Royal Cornwall Hospital, Truro, , United Kingdom

Wirral University Teaching Hospital Nhs Foundation, Wirral, , United Kingdom

Wrexham Maelor, Wrexham, , United Kingdom

Contact Details

Name: Hashim Ahmed, PhD, FRCS

Affiliation: Imperial College London

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: